top of page

What Is TruDOSE™?

TruDOSE™ IV platelet therapy is a patent pending regenerative treatment utilizing the healing power of your body’s own blood platelets. When given at the right dose, your platelets can restart your body’s immune and repair systems to get rid of systemic inflammation. Since 2018, TruDOSE™ IV platelet therapy has treated thousands of patients around the globe with systemic inflammation and chronic conditions and gained a word of mouth following from patients.

 

  • At the most basic understanding, TruDOSE™ IV Platelet Therapy is a minimally invasive blood draw similar to having your labs drawn.

  • The procedure begins with testing a few drops of your blood and is analyzed by TruDOSE™ Regenerative Technology.

  •  TruDOSE™ Regenerative technology utilizes proprietary metrics and analytics to determine a personalized, dose-specific treatment meant only for you and your specific condition.

  • Within minutes of the analyzing, a specific amount of blood is drawn from your arm and processed via centrifugation.

  • A 15 minute, two step centrifugation process is executed by the clinical staff to produce your personalized, dose specific TruDOSE™ IV platelet therapy.

  • Once your therapy is ready, it is administered intravenously back into your arm by a medical provider.

  • The entire patient experience lasts about an hour from start to finish.

 

It's simple. Its minimally invasive. It's your blood with minimal risks. At the right dose, the TruDOSE™, this therapy can heal your body.

Hear From Our Founder, Tapley Holland

Tapley_edited.jpg

Amazing All Star Zoom Call With Numerous Healing Testimonies

Do I Need TruDOSE™?

RedDroplet.png

TruDOSE™ Platelet Therapy™ heals and restores your body with precision.

Your blood. Dose specific. Personalized. Find healing with TruDOSE™.

For more information about TruDOSE™ click one of the buttons below

I'd like to offer TruDOSE™ in my clinic

I'm a patient and would like more info about TruDOSE™

©2024 TruDOSE™ Regenerative Technology

This web site is provided for educational and informational purposes about platelet therapy and does not constitute providing medical advice or professional services. All information provided on this website is from physician observational evidence or patient testimonials and not published clinical studies or clinical trials. As such, this information should not be used for diagnosing or treating a health problem or disease.  Individuals seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. No physician-patient relationship is created by this web site or its use.

​

As of June 1, 2021, the FDA updated their guidance on all “stem cell regenerative” therapies. The FDA makes a clear distinction on the use of autologous (from you) platelet therapies compared to donor cell therapies (cells not from you). The FDA1 states: “This guidance also does not apply to products that fall outside the definition of HCT/P in 21 CFR 1271.3(d). For example, platelet rich plasma (PRP, blood taken from an individual and given back to the same individual as platelet rich plasma) is not an HCT/P under 21 CFR Part 1271 because it is a blood product. Accordingly, FDA does not apply the criteria in 21 CFR 1271.10(a) to PRP, and PRP is outside the scope of this guidance.”

​

https://www.fda.gov/media/109176/download

bottom of page